Not provided
Not provided
Not provided
Not provided
Not provided
All patients during the study period were subjected to peripheral blocks or were excluded from the study due to exclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Thessaly | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to orthopedic operations.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I | Placebo Comparator | Administration of a placebo capsule 1 hour prior to the surgical operation |
|
| Group II | Experimental | Administration of 75mg of pregabalin 1 hour prior to the surgical operation |
|
| Group III | Experimental | Administration of 150mg of pregabalin 1 hour prior to the surgical operation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo oral capsule | Drug | Placebo oral capsule administered 1 hour prior to the surgical operation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of postsurgical catheter-related bladder discomfort after preoperative pregabalin administration | Assessment of discomfort will be made by a scale of four (1=no discomfort, 2=mild discomfort reported on questioning only, 3=moderate discomfort, urge to pass urine reported by the patient without questioning, 4= severe discomfort, urge to pass urine accompanied by behavioral responses, such as flailing limbs, strong vocal responses or attempts to pull the catheter out) | Change from preoperative status to postoperative one at 0, 1, 2, 6, 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative pain assessed by NPRS scale (Numeric Pain Rating Scale) | The goal is to achieve pain scores<3 as these are assessed by the NPRS scale. In order to achieve that we will record the total amount of milligrams of analogues of morphine administered in the first 24 hours postoperatively | Total amount of analgesics in morphine analogues administered in the first 24 hours postoperatively |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sofia Poulopoulou, Head of department | Anticancer Hospital of Athens 'Saint Savvas' | Study Director |
| Eleni Arnaoutoglou, Professor of Anesthesiology | University of Thessaly, Medical School, Anesthesiology Clinic | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Anticancer Hospital of Athens "Saint Savvas" | Athens | 115 22 | Greece | |||
| University of Thessaly, Medical School |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16415311 | Background | Agarwal A, Dhiraaj S, Singhal V, Kapoor R, Tandon M. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth. 2006 Mar;96(3):377-80. doi: 10.1093/bja/ael003. Epub 2006 Jan 16. | |
| 25335575 | Background |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, double-blind,randomized, placebo controlled trial
Not provided
Not provided
Not provided
| Pregabalin Oral Capsule [Lyrica] 75mg | Drug | Pregabalin Oral Capsule [Lyrica] 75 mg administered 1 hour prior to the surgical operation |
|
|
| Pregabalin Oral Capsule [Lyrica] 150 mg | Drug | Pregabalin Oral Capsule [Lyrica] 150 mg administered 1 hour prior to the surgical operation |
|
|
| Adverse effects of the drug | Postoperative nausea and vomiting, confusion, vertigo, blurred vision, dry mouth,sedation, dizziness | All adverse effects observed in the first 24 hours postoperatively |
| Assessment of postoperative sedation | The Ramsay Sedation Scale is used to measure different levels of sedation in medical patients (1=Patient is anxious and agitated or restless, or both 2=Patient is co-operative, oriented, and tranquil, 3=Patient responds to commands only, 4=Patient exhibits brisk response to light glabellar tap or loud auditory stimulus, 5=Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus, 6=Patient exhibits no response) | In the operating theatre immediately after patient's extubation |
| Volos |
| 38221 |
| Greece |
| Bai Y, Wang X, Li X, Pu C, Yuan H, Tang Y, Li J, Wei Q, Han P. Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery. J Endourol. 2015 Jun;29(6):640-9. doi: 10.1089/end.2014.0670. Epub 2014 Dec 9. |
| 25200037 | Background | Srivastava VK, Agrawal S, Kadiyala VN, Ahmed M, Sharma S, Kumar R. The efficacy of pregabalin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled double-blind study. J Anesth. 2015 Apr;29(2):212-6. doi: 10.1007/s00540-014-1911-x. Epub 2014 Sep 9. |
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided